SEC Filings

Filing date	Form	Description	Filing Group	View
January 25, 2023	CORRESP	CORRESP	Other	View HTML 0001104659-23-006388.pdf 0001104659-23-006388.rtf
January 20, 2023	8-A12B	Registration of certain classes of securities 12(b) of the Securities Exchange Act	Registration Statements	View HTML 0001104659-23-005236.pdf 0001104659-23-005236.rtf 0001104659-23-005236.xls
January 19, 2023	UPLOAD	UPLOAD	Other	View HTML 0000000000-23-000560.pdf 0000000000-23-000560.rtf
January 13, 2023	F-4/A	Amendment to a previously filed F-4	Registration Statements	View HTML 0001104659-23-003636.pdf 0001104659-23-003636.rtf 0001104659-23-003636.xls
January 13, 2023	CORRESP	CORRESP	Other	View HTML 0001104659-23-003637.pdf 0001104659-23-003637.rtf
January 6, 2023	UPLOAD	UPLOAD	Other	View HTML 0000000000-23-000192.pdf 0000000000-23-000192.rtf
December 28, 2022	F-4	Registration statement for foreign private issuers issued in certain business transactions	Registration Statements	View HTML 0001104659-22-130315.pdf 0001104659-22-130315.rtf 0001104659-22-130315.xls
December 28, 2022	CORRESP	CORRESP	Other	View HTML 0001104659-22-130318.pdf 0001104659-22-130318.rtf
December 16, 2022	UPLOAD	UPLOAD	Other	View HTML 0000000000-22-013608.pdf 0000000000-22-013608.rtf
December 7, 2022	DRS/A	mendment to a previously filed DRS	Registration Statements	View HTML 0001104659-22-125040.pdf 0001104659-22-125040.rtf 0001104659-22-125040.xls

Data provided by Kaleidoscope.

Print Page

Email Alerts

RSS Feeds

Contact IR

Site Map Terms of Use Privacy

Contact Info

LakeShore Biopharma, Ltd.

11 Firstfield Road Suite A
Gaithersburg, Maryland 20878 USA

Tel: +1 (212) 537-4035

ir@lakeshorebio.com